+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Pandemic Influenza Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768082
  • Report
  • April 2019
  • Region: Global
  • 96 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Accelovance Inc
  • Altimmune Inc
  • AstraZeneca Plc
  • CSL Ltd
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
The global clinical trial report- “2019 Pandemic Influenza Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pandemic Influenza. It presents in-depth analysis of Pandemic Influenza clinical trials across markets and companies. The research work is for providing complete understanding into trends in Pandemic Influenza.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Pandemic Influenza clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Pandemic Influenza

The research work is prepared through extensive and continuous research on Pandemic Influenza trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Pandemic Influenza patients are identified
  • The report includes panorama of Pandemic Influenza clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Pandemic Influenza clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Accelovance Inc
  • Altimmune Inc
  • AstraZeneca Plc
  • CSL Ltd
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Pandemic Influenza Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Pandemic Influenza Clinical Trials by Region
2.2.2 Average Enrollment of Pandemic Influenza Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Pandemic Influenza Treatment, 2019

3. Region wise Pandemic Influenza Clinical Trials
3.1 Asia Pacific Pandemic Influenza Clinical Trials by Country
3.2 Europe Pandemic Influenza Clinical Trials by Country
3.3 North America Pandemic Influenza Clinical Trials by Country
3.4 Middle East and Africa Pandemic Influenza Clinical Trials by Country
3.5 South and Central America Pandemic Influenza Clinical Trials by Country

4. Pandemic Influenza Clinical Trial Trends
4.1 Start Year wise Pandemic Influenza Clinical Trials
4.2 Phase wise Pandemic Influenza Clinical Trials
4.3 Trial Status wise Pandemic Influenza Clinical Trials
4.4 Trial Type wise Pandemic Influenza Clinical Trials

5. Pandemic Influenza Average Enrollment Trends
5.1 Average Enrollment in Pandemic Influenza Trials by Year
5.2 Average Enrollment in Pandemic Influenza Trials by Phase
5.3 Average Enrollment in Pandemic Influenza Trials by Status
5.4 Average Enrollment in Pandemic Influenza Trials by Type of Trial

6. Companies Participating in Pandemic Influenza Clinical Trials
6.1 Pandemic Influenza Trials by Sponsor Type
6.2 Pandemic Influenza Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Pandemic Influenza Trials- Phase 1
7.2 Pandemic Influenza Trials- Phase 2
7.3 Pandemic Influenza Trials- Phase 3
7.4 Pandemic Influenza Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Pandemic Influenza Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Pandemic Influenza Clinical Trials and Enrolment
Figure 5: Europe - Country wise Pandemic Influenza Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Pandemic Influenza Clinical Trials and Enrolment
Figure 7: North America - Country wise Pandemic Influenza Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Pandemic Influenza Clinical Trials and Enrolment
Figure 9: Pandemic Influenza Clinical Trials by Phase
Figure 10: Pandemic Influenza Clinical Trials by Trial Status
Figure 11: Pandemic Influenza Clinical Trials by Type
Figure 12: Pandemic Influenza Clinical Trials by Sponsor Type
Figure 13: Pandemic Influenza Clinical Trials by Leading Sponsors
Figure 14: Pandemic Influenza Average Enrollment by Phase
Figure 15: Pandemic Influenza Average Enrollment by Trial Status
Figure 16: Pandemic Influenza Average Enrollment by Type
Figure 17: Pandemic Influenza- Average Enrolment by Type of Sponsors
Figure 18: Pandemic Influenza- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Pandemic Influenza Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Pandemic Influenza Clinical Trials and Enrolment
Table 5: Europe - Country wise Pandemic Influenza Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Pandemic Influenza Clinical Trials and Enrolment
Table 7: North America - Country wise Pandemic Influenza Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Pandemic Influenza Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Pandemic Influenza Average Enrollment by Phase
Table 15: Pandemic Influenza Average Enrollment by Trial Status
Table 16: Pandemic Influenza Average Enrollment by Type
Table 17: Pandemic Influenza- Average Enrolment by Type of Sponsors
Table 18: Pandemic Influenza- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • Accelovance Inc
  • Altimmune Inc
  • AstraZeneca Plc
  • CSL Ltd
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Microgen Scientific Industrial Company for Immunobiological Medicines
  • Novartis AG
  • Novavax Inc
  • Sanofi
Note: Product cover images may vary from those shown
Adroll
adroll